Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Rumination-Tailored Guided Internet-Based CBT-I for University Students (RUM-CBTI)

28 maja 2026 zaktualizowane przez: Rasool Hamidi Choolabi, Shahid Beheshti University of Medical Sciences

A Pilot Randomized Trial of Rumination-tailored Feedback in Guided Internet-based CBT-I for University Students

The goal of this clinical trial is to evaluate whether adding rumination-tailored, rule-based personalized feedback to guided internet-based cognitive behavioral therapy for insomnia (iCBT-I) improves treatment outcomes in university students with insomnia symptoms.

The main questions it aims to answer are:

Does rumination-tailored feedback improve insomnia severity compared to standard guided iCBT-I? Does the addition of personalized feedback improve rumination, treatment adherence, and treatment satisfaction compared to standard guided iCBT-I? Researchers will compare three conditions: (1) standard guided iCBT-I, (2) guided iCBT-I with additional rumination-tailored feedback, (3) waitlist control group, to determine whether the enhanced intervention leads to superior clinical and behavioral outcomes.

Participants will:

complete an online screening and baseline assessment be randomly assigned to one of three study conditions receive either guided iCBT-I, guided iCBT-I with rumination-tailored feedback, or no intervention (waitlist condition) complete a structured internet-based CBT-I program over several weeks (for intervention arms) receive weekly guidance according to group allocation complete post-treatment and follow-up questionnaires assessing sleep, rumination, and treatment experience

Przegląd badań

Szczegółowy opis

This study is a pilot randomized controlled trial with three parallel arms. Participants will be randomly assigned to either (1) guided internet-based cognitive behavioral therapy for insomnia (iCBT-I), (2) guided iCBT-I with additional rumination-tailored, rule-based personalized feedback, or (3) a waitlist control group. The study aims to evaluate the feasibility and preliminary efficacy of integrating targeted cognitive feedback into a digital insomnia intervention.

The study will recruit university students with clinically relevant insomnia symptoms. Participants will be included if they are university students, 18 years of age or older, fluent in Persian and able to read and understand online study materials, reporting clinically relevant insomnia symptoms, and willing to complete online questionnaires and use the internet-based intervention platform.

Participants will be excluded if they have a current severe psychiatric condition requiring immediate treatment, such as psychosis, mania, or active suicidal intent; are currently receiving another structured insomnia treatment or CBT-I program; have a diagnosed sleep disorder other than insomnia that would better explain the sleep problem, such as sleep apnea, restless legs syndrome, or narcolepsy; work regular night shifts or have a highly irregular sleep-wake schedule that would make the intervention unsuitable; have a substance use problem severe enough to interfere with participation; or have a cognitive or language problem that prevents completion of the online materials or questionnaires.

The base intervention consists of a structured guided internet-based CBT-I program including standard components such as sleep restriction, stimulus control, cognitive restructuring, sleep hygiene education, and relaxation techniques. Participants receive weekly brief supportive guidance during the intervention period (for intervention arms only).

In the experimental condition, participants additionally receive rumination-tailored, rule-based personalized feedback generated based on their levels of repetitive negative thinking and sleep-related cognitive arousal. The feedback is predefined according to decision rules and is not dynamically generated. The feedback targets repetitive negative thinking patterns, sleep-related worry and cognitive arousal, and maladaptive pre-sleep cognition. Feedback is delivered in written format alongside standard CBT-I guidance and is designed to complement, not replace, core therapeutic components.

Participants in the waitlist control condition will not receive immediate intervention during the study period. After study completion, they will be offered access to the guided iCBT-I program.

The primary outcome is insomnia severity measured using a validated insomnia questionnaire. Secondary outcomes include repetitive negative thinking (rumination), treatment adherence, treatment satisfaction, and dropout rate.

Participants will be randomly allocated to one of three study conditions using a parallel group randomized design with balanced allocation. Due to the nature of the intervention, participants and intervention providers cannot be blinded. Outcome assessment is based on self-report measures, and participants will be aware of their group allocation.

Assessments will be conducted at baseline, post-intervention, and follow-up. Data collection will be fully online through a secure platform. Participants will complete weekly monitoring measures during the intervention period.

Feasibility will be evaluated through recruitment rate, retention, and adherence to intervention modules. Acceptability will be assessed using self-reported treatment satisfaction.

Insomnia is frequently maintained by cognitive arousal and repetitive negative thinking, particularly rumination before sleep. While standard CBT-I is effective, variability in treatment response suggests a need for personalization. This study investigates whether augmenting CBT-I with structured rumination-focused feedback can improve engagement and outcomes in a scalable digital format.

Typ studiów

Interwencyjne

Zapisy (Szacowany)

70

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Kopia zapasowa kontaktu do badania

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dorosły
  • Starszy dorosły

Akceptuje zdrowych ochotników

Tak

Opis

Inclusion Criteria:

  • University students
  • Aged 18 years or older
  • Fluent in Persian and able to read and understand online study materials
  • Reporting clinically relevant insomnia symptoms as indicated by screening measures
  • Willing to complete online questionnaires and participate in an internet-based intervention program

Exclusion Criteria:

  • Current severe psychiatric condition requiring immediate clinical attention (e.g., psychosis, mania, or active suicidal ideation)
  • Current participation in another structured psychological treatment for insomnia (including CBT-I)
  • Presence of a diagnosed sleep disorder other than insomnia that better explains sleep problems (e.g., sleep apnea, restless legs syndrome, narcolepsy)
  • Regular night-shift work or highly irregular sleep-wake schedule that would interfere with CBT-I protocols
  • Severe substance use problems that may interfere with participation or adherence
  • Cognitive, language, or technological limitations that prevent completion of online assessments or intervention materials

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Brak interwencji: Kontrola listy oczekujących
Aktywny komparator: Guided CBT-I
Participants receive a structured guided internet-based cognitive behavioral therapy program for insomnia (iCBT-I). The intervention includes core CBT-I components such as sleep restriction, stimulus control, cognitive restructuring, sleep hygiene education, relaxation techniques, and sleep-related behavioral recommendations. The program is delivered online over several weeks. Participants receive brief weekly supportive guidance throughout the intervention period.
Eksperymentalny: CBT-I + Rumination Feedback
Participants receive a structured guided internet-based cognitive behavioral therapy program for insomnia (iCBT-I). The intervention includes core CBT-I components such as sleep restriction, stimulus control, cognitive restructuring, sleep hygiene education, relaxation techniques, and sleep-related behavioral recommendations. The program is delivered online over several weeks. Participants receive brief weekly supportive guidance throughout the intervention period.
Participants receive predefined personalized feedback targeting repetitive negative thinking and rumination-related cognitive processes associated with insomnia. Feedback is generated according to rule-based decision algorithms derived from participants' rumination severity, brooding and reflection patterns, treatment adherence, and longitudinal change during the intervention period. Feedback messages focus on cognitive distancing, reduction of maladaptive repetitive thinking, attentional regulation, behavioral activation, and structured problem solving. Personalized feedback is delivered in written format alongside the standard guided iCBT-I program.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Insomnia Severity Index (ISI) Score
Ramy czasowe: Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 10)
Insomnia severity will be assessed using the Persian version of the Insomnia Severity Index (ISI). Higher scores indicate greater insomnia severity.
Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 10)

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Ruminative Responses Scale (RRS-22) Total Score
Ramy czasowe: Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 10)
Rumination severity will be assessed using the Persian version of the 22-item Ruminative Responses Scale (RRS-22). Higher scores indicate greater repetitive negative thinking and rumination.
Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 10)
Dysfunctional Beliefs and Attitudes About Sleep Scale (DBAS) Score
Ramy czasowe: Time Frame: Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 10)
Sleep-related dysfunctional beliefs and attitudes will be assessed using the Persian version of the Dysfunctional Beliefs and Attitudes About Sleep Scale (DBAS). Higher scores indicate greater maladaptive sleep-related cognitions.
Time Frame: Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 10)
Pittsburgh Sleep Quality Index (PSQI) Score
Ramy czasowe: Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 10)
Sleep quality will be assessed using the Persian version of the Pittsburgh Sleep Quality Index (PSQI). Higher scores indicate poorer subjective sleep quality.
Baseline (Week 0), post-intervention (Week 6), and follow-up (Week 10)
Client Satisfaction Questionnaire (CSQ-8) Total Score
Ramy czasowe: Post-intervention (Week 6)
Treatment satisfaction will be assessed using the Client Satisfaction Questionnaire (CSQ-8). Higher scores indicate greater satisfaction with the intervention.
Post-intervention (Week 6)
Intervention Module Completion Rate
Ramy czasowe: Throughout the 6-week intervention period
Treatment adherence will be assessed by the percentage of completed intervention modules during the study period.
Throughout the 6-week intervention period
Sleep Diary Completion Rate
Ramy czasowe: Throughout the 6-week intervention period
Adherence to daily sleep monitoring will be assessed by the percentage of completed sleep diary entries.
Throughout the 6-week intervention period
Study Dropout Rate
Ramy czasowe: From baseline (Week 0) to post-intervention assessment (Week 6)
Dropout rate will be defined as discontinuation of participation before completion of the post-intervention assessment.
From baseline (Week 0) to post-intervention assessment (Week 6)

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Przydatne linki

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Szacowany)

1 czerwca 2026

Zakończenie podstawowe (Szacowany)

1 września 2026

Ukończenie studiów (Szacowany)

1 października 2026

Daty rejestracji na studia

Pierwszy przesłany

23 maja 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

28 maja 2026

Pierwszy wysłany (Rzeczywisty)

3 czerwca 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

3 czerwca 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

28 maja 2026

Ostatnia weryfikacja

1 maja 2026

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

TAK

Opis planu IPD

De-identified individual participant data (IPD) collected in this study will include demographic information, baseline characteristics, questionnaire responses (e.g., insomnia severity, rumination, sleep quality), treatment adherence indicators, and treatment outcome measures. No directly identifiable personal information will be shared. All data will be fully anonymized prior to sharing.

Ramy czasowe udostępniania IPD

De-identified IPD and supporting documents will become available after publication of the primary study results or within 12 months after study completion, whichever occurs first. Data will remain available for a minimum of 5 years following publication.

Kryteria dostępu do udostępniania IPD

Access to de-identified individual participant data and supporting documents will be granted upon reasonable request to qualified researchers for academic and non-commercial purposes. Requests will be reviewed by the principal investigator. Data will be shared under a data use agreement to ensure confidentiality, ethical use, and compliance with institutional and ethical guidelines. Only de-identified datasets will be shared.

Typ informacji pomocniczych dotyczących udostępniania IPD

  • PROTOKÓŁ BADANIA
  • SOK ROŚLINNY
  • ICF
  • ANALITYCZNY_KOD

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj